Please login to the form below

Not currently logged in
Email:
Password:

Bayer donation for WFH

Bayer HealthCare has donated $250,000 to the World Federation of Haemophilia, solidifying its continued support of sufferers of blood disorders
Bayer HealthCare has donated $250,000 to the World Federation of Haemophilia (WFH), solidifying its continued support of sufferers of blood disorders.

The company has also given away 950,000 units of its Kogenate treatment to those affected by the disease in the international community, marking World Haemophilia Day on April 17. Events and fund raising activities were organised to increase awareness of blood disorders.

Dr Gunnar Riemann, member of the company's executive committee, said: "Bayer reaffirms its commitment to advance haemophilia care around the world so that patients can enjoy a high quality of life."

"We look forward to continuing our tradition of providing innovative products and services that help people live the lives they choose," he added.

Bayer has donated more than £1m to the WFH over the past four years. It has granted financial assistance totalling $13m to researchers and caregivers through the Bayer Haemophilia Awards Program (BHAP) since its inception six years ago. In 2007, Bayer gave away a large amount Kogenate to China, helping to avert a humanitarian crisis.

Mark Skinner, president of the WFH, said: "With Bayer as a committed partner to the haemophilia community, we can make great progress in achieving our common vision of 'treatment for all'."

17th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics